[1]
A. Al-Mansouri and L. El-Sayed, “Establishing Scrutiny and Reporting Requirements in the Drug Development Life Cycle: Research, Sales, Pricing, and Patient Data Security”, QJCTH, vol. 9, no. 1, pp. 34–45, Mar. 2024.